Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

(S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone

    • Product Name: (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone
    • CAS No.: 1312691-15-0
    • Chemical Formula: C17H14ClIO3
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 929152
    Iupac Name (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone
    Molecular Formula C17H14ClIO3
    Appearance Solid (exact color may vary)
    Solubility Soluble in organic solvents such as DMSO and DMF
    Optical Rotation Specific to (S)-enantiomer
    Smiles C1COCC1OC2=CC=C(C=C2)C(=O)C3=C(C=CC(=C3)I)Cl
    Inchi InChI=1S/C17H14ClIO3/c18-16-10-12(19)6-7-15(16)17(20)13-2-4-14(5-3-13)22-11-1-8-21-9-11/h2-7,10-11H,1,8-9H2/t17-/m0/s1
    Chirality S-enantiomer
    Storage Conditions Store in a cool, dry place, protected from light
    Usage For research and chemical synthesis purposes

    As an accredited (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 1-gram sample is supplied in a clear, tightly sealed amber glass vial, labeled with chemical name, purity, and hazard warnings.
    Container Loading (20′ FCL) Container Loading (20′ FCL) for (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone: Secure, moisture-protected packaging, optimized stacking, compliant with chemical safety regulations for international transport.
    Shipping This chemical is shipped in tightly-sealed containers compliant with hazardous material regulations. Packaging ensures protection from moisture, light, and physical damage. All shipments include proper labeling, safety documentation, and follow International Air Transport Association (IATA) and local guidelines for transport of hazardous substances. Temperature control may be used if required.
    Storage (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone should be stored in a tightly sealed container under inert atmosphere, protected from light and moisture. Keep at 2–8°C in a well-ventilated, dry area, away from strong oxidizers and incompatible materials. Properly label the container and use secondary containment to prevent spills and accidental exposure. Handle in accordance with standard laboratory safety procedures.
    Shelf Life The shelf life of (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone) is typically 2–3 years under cool, dry conditions.
    Application of (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone

    Applications of (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone in Industrial Manufacturing

    (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone serves as a key advanced intermediate in the synthesis of complex molecules for specialty pharmaceuticals, agrochemical actives, chiral chemical research, and fine organic material production. As an original manufacturer, we support end users in tightly regulated industries with reliable material quality and in-depth technical integration for downstream applications.

    1. Chiral Pharmaceutical Intermediate Synthesis

    Pharmaceutical production sites utilize this advanced intermediate for multi-step synthesis of highly regulated, chiral APIs, especially in oncology and neurological therapy development pipelines. Users commonly implement its chirality and halogenated scaffold to construct key pharmacophores during API assembly, demanding high purity throughout scale-up.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Agrochemical Active Ingredient Development

    Agrochemical R&D utilizes this intermediate as a building block for synthesis of new-generation pesticides and fungicides, especially for chiral pyrazole and phenoxy derivatives. It enables selective mono-halogenation in lead molecule construction, providing effective scaffolds meeting advanced crop protection efficacy.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Custom Synthesis for Chemical Research Reagents

    Academic and corporate R&D laboratories use this compound for library generation, structure–activity relationship (SAR) studies, and probe molecule development in medicinal chemistry and chemical biology. Its stereocenter and dual halogen motifs enable route flexibility for research-scale chiral amide, ketone, or aryl ether formation.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Electronic Chemical and Organic Material Synthesis

    Specialty electronic material manufacturers integrate this compound into synthetic routes for the preparation of electroactive intermediates and advanced organic semiconductors. Its halogenated aromatic core facilitates the assembly of complex architectures for molecular electronics and display technology applications.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. Chiral Ligand and Catalyst Synthesis

    Catalysis specialists and fine chemicals producers deploy this molecule for constructing complex, enantioselective ligands and organocatalyst frameworks. Its chiral and halogen-rich architecture supports key ligand design for asymmetric reactions in pharmaceutical and specialty fine chemical production.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone: Experience from the Manufacturer’s Bench

    Developing the Compound: Precision Over Conformity

    In the lab, clarity and reliability mean everything. (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone came together after dozens of iterations with our glassware and reactors, each batch offering insight. The process underscores patience and a refusal to cut corners, guiding the steps that set this molecule apart from the swath of similar halogenated aromatic ketones. A major factor lies in managing the chlorination and iodination: controlling para- and ortho- selectivity, checking NMR and LC-MS with each stage. Precision with these active groups directly shapes the downstream reactivity, and even a minor slip carries consequences for product purity.

    On the production line, our technicians avoid generic routines. The choice of reagents and solvents for installing the tetrahydrofuran-3-yloxy moiety draws on hours of hands-on evaluation, always tuned to minimize side reactions—because every percent drop in yield means a more expensive bottle for the customer and lost effort from the team. We do not rely on one-size-fits-all protocols or pre-mixed kits; experience pushing back against visible crystallization or persistent side bands in chromatography teaches more than any standard operating procedure. By investing this time and attention at each step, we keep batch reproducibility at its highest, even over months of continuous manufacture.

    Structure, Purity, and Why Small Differences Matter

    The value of (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone rests in its tightly defined structure. Labs focused on asymmetry, especially in pharmaceutical research, know every atom’s placement holds potential for different reactivity or binding. The stereochemistry sets our material apart from simple racemic mixtures; here, we commit to absolute configuration, measured by optical rotation and verified in house after each synthesis.

    Those treating this compound as a check box in their project pipeline risk overlooking the complexity beneath the label. Ordinary chloroiodophenyl ketones often mix R and S forms with little effort paid to separation. Overlooked details like this undermine biological data, especially in chiral drug discovery. By putting the equipment and trained staff behind every step of chiral resolution, and confirming our product with spectroscopic data before shipping, we keep reliability in focus. This focus only comes from knowing how one misstep in stereochemistry derails months of work downstream.

    The market supplies many analogues: some cheap, some easy to order, others touted for speed. In real use, differences emerge. Batches from unproven sources run the risk of higher polyhalogenated byproducts, incomplete conversion, or worse—the wrong major enantiomer. Such issues become obvious in analytical purity tests and bioassays. Our in-house experience has shown that only measured handling of organoiodides yields clean material. Post-synthesis purification with column chromatography and selective crystallization clears years of accumulated learning to keep purity above 99%. No automated system picks up on these subtleties; it’s the patience and eyes of a chemist at each stage that gives end users more than a number on a COA.

    Applications Shaped by Real-World Practice

    This molecule’s reputation comes from its performance in research settings, especially as an advanced intermediate for asymmetric synthesis or halogenated aromatic building blocks. Over time, clients working on kinase inhibitors, non-linear optical materials, or selective labeling agents have shared their needs with us. These interactions reinforce how a specific steric arrangement, and the presence of both chloro and iodo substituents, promote selectivity in cross-coupling reactions or late-stage functionalizations. Early on, some attempted to substitute cheaper analogues, only to find inconsistent yields or obscure side products when trying Stille or Suzuki reactions. The difference quickly emerges in actual yields and spectroscopy data.

    Our team knows researchers often drive novel chemistry with limited resources: time, funds, dedicated fume hood space. That’s where manufacturing experience helps. By maintaining the tetrahydrofuran-3-yloxy group intact, and avoiding conditions that cleave or alter the oxygen linker, we protect the versatility downstream. Some clients reported that small-batch or imported alternatives suffered from instability or unwanted hydrolysis. Our protocol skips harsh acid washes and strips residual palladium or copper catalysts during post-reaction workup, leaving minimal trace metals. That's not just better practice—it means the material integrates smoothly into sensitive synthetic routes, with less troubleshooting on the chemist’s plate.

    Improving Over Generic Supply: Precision from the Source

    Working directly in synthesis for years, we see little patience among working chemists for “almost right” batches. Researchers demand repeated, reliable performance from each shipment, regardless of project scale. Consistency matters for multi-step syntheses, especially in pharma or materials applications where intermediates pass through many hands and months. By linking process control at every stage with iterative learning—from changes in catalyst loading to tweaks in crystallization solvents—we bridge the gap between what works on paper and what runs cleanly in the flask.

    Chelation behavior and aromatic substitution pattern make a visible difference in many modern transformations. Our familiarity with common cross-coupling challenges, such as undue dehalogenation or incomplete oxidative addition, has led us to add more stringent in-process checks, with direct communication between quality analysts and floor chemists. One instance involved a subtle shift in NMR spectra during a run, which staff caught due to training in spotting abnormal aromatic coupling. Drilling down on this, we traced a latent impurity in a commercial iodine source and replaced it the next run. Not every supplier learns this way—or takes the time to eliminate such issues at their own expense.

    What does this mean for end users? A decade of manufacturing this class of compounds narrows the performance gap between project planning and bench success. The choices made during production—ranging from column selection to temperature ramping—shape the scope of downstream experiments. Instead of supplying a generic intermediate, we offer process-verified, user-tested material that saves time, cost, and troubleshooting for everyone downstream. The compound becomes part of a researcher’s workflow, not a stumbling block they lose days re-purifying or second-guessing.

    Safety, Stewardship, and Operator Knowledge

    Halogenated aromatic ketones present unique handling considerations. We balance lab safety, staff wellness, and environmental stewardship in every batch. This involves deliberate decisions on waste management, containment, and exposure reduction—not just lip service. Technicians receive targeted training in handling chloro and iodo compounds, from the first weighing to the final vial fill. Unit operations go beyond standard fume hood protocols: respirators, glove selection, and precise logbooks. These safeguards stem from years of real incidents, inspections, and corrections, not theoretical guidelines.

    For many newer manufacturers, discarding reaction mother liquors and halogenated byproducts remains an afterthought. We treat this as a shared industry responsibility, implementing on-site reclamation where possible and working with vetted disposal partners. This decision cuts into margins, but keeps the local environment and the broader chemical supply chain protected. Every kilo handled and transferred records these lessons, so a safer material reaches every lab. Operations staff carry out periodic drills and engage with safety audits directly, knowing their health forms the backbone of consistent, safe production.

    Supporting Client Adaptation: Dialogue, Not Dictation

    Feedback from users directs many small, steady improvements to our (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone. Lab groups across several continents report back on solubility, reactivity, and scale-up quirks as they arise, not filtered by intermediaries. Our technical team answers with practical suggestions rooted in shared production experience, not theory alone.

    An example came from an academic group facing inconsistent dissolution in their methyl tert-butyl ether and dichloromethane combinations. Instead of a standard answer, our staff shared insights gained from microbatch solubility tests during QA, which had led to a slight increase in room temperature stirring and improvement in crystallinity. Fielding those types of real-time questions helps us refine particle size distribution in the packaging process. That dialogue means product evolution favors the realities of lab work, instead of just what works in our own facility.

    Long-Term Reliability Drives Value Beyond Price

    Chemical research is often measured in failed reactions, lost time, and occasional breakthroughs. Every new project faces uncertainty; reducing unknowns in materials increases the likelihood that results reflect true science instead of unexpected contamination. Across years of producing (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone, we have witnessed customers shift from testing several sources to sticking with our product—a loyalty built not just from documentation, but from actual batch performance and troubleshooting support.

    What sets our material in a different class becomes evident with repeated use. Each lot is accompanied by current, detailed analytical data, supported by a laboratory notebook referencing process details unique to that batch. If a researcher uncovers an anomaly in LC-MS or GC, they reach the chemist who made that lot for perspective, instead of facing a call center or web portal. This transparency replaced frustration on multiple occasions, where deeper insight meant the difference between scrapping weeks of work or simply adjusting a purification scheme.

    Process learning is cumulative: changes in glassware cleanliness, shifts in water content of reagents, even the decision to tweak stirring speed impact the final yield and purity. We archive this knowledge, teach it in annual training, and feed it back into every planning session. New staff shadow experienced operators, learning why shortcuts rarely pay off in specialty compounds like this. Each mistake avoided this way strengthens overall reliability. Where competitors may ship product “as is” with boilerplate paperwork, we stake our reputation on predictability earned batch by batch.

    Continuous Process Refinement: Small Adjustments, Big Outcomes

    Innovation in the plant rarely means wholesale overhauls; instead, repeated micro-adjustments shape long-term results. Attrition from repeated recrystallizations cuts yield, hurts throughput, and increases solvent usage. Over multiple campaigns, operators found that a single, precise solvent addition before the final filtration provided better crystal morphology, improving recovery and downstream texture. These refinements originate from operator feedback, not an upper-management mandate. Small learning, repeatedly captured, drives overall product advancement.

    Batch-to-batch comparisons often form the most telling checkpoints. More than one client scrutinized subtle differences in melting point or solubility in competitive sources, raising flags with their analytical teams. This direct input returns to the site each quarter; manufacturing then adapts stirring speeds, filtration methods, or column media to preempt problems at source. The cycle continues, as each new batch strengthens our process and customer confidence.

    Another lesson comes from transition-metal catalyzed routes to install the iodo group. Early runs led to minor byproduct formation from competing oxidative addition, seen as faint shadows on TLC and slight dips in assay yield. Iterative changes—switching from Pd(PPh3)4 to a more robust Pd-catalyst, introducing controlled cooling on addition, and customizing quenching—eliminated the issue. Operators remember years down the line; new hires see these improvements recorded in process manuals, practiced at the bench, and repeated for every subsequent batch.

    Different from the Crowd: The Manufacturer’s Distinct Edge

    Direct manufacturing control lets us escape the generic mold. Portfolio expansion reflects true performance, not just theoretical gaps. Our approach resists cost-cutting capable of endangering purity, consistency, or safety. Instead of chasing every marginal saving, we reinvest those resources into better staff training, improved analytics, and upgraded plant infrastructure.

    Product stewardship extends beyond immediate labwork. From consistent sourcing of raw halides to traceability of every reagent lot, commitment runs through our operation. Years where global supply chains stumbled forced flexibility and built resilience, so we now keep buffer stocks and alternate supplier relationships to dampen shocks for our end users. This invisible infrastructure assures reliability for every vial dispatched, regardless of outside circumstances.

    Direct input from user labs across pharma, academia, and materials research fertilizes new applications and process upgrades. Instead of chasing volume, the focus remains on quality, reproducibility, and transparent partnership. This approach gives researchers confidence their real-world trials and scale-ups run smoothly, letting science—not suboptimal chemicals—set the pace.

    From Synthesis to Real Use: Insights Accumulated at Source

    Years of direct synthesis and close engagement with users sharpen awareness of each functional group’s impact, every trace impurity’s risk, and every logistical bottleneck’s consequence. Processing (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yloxy)phenyl)methanone for repeated rounds builds that knowledge into the material itself. Handled well, it becomes more than an intermediate: it grows into an enabler for serious chemistry, with reliability and support built in at the source. From reactor to R&D bench, only the producer with both skill and pride in their work shapes the difference that scientific teams feel every day, batch after batch.